RECRUITING

Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

Talk to us

Conditions

Metastatic Pancreatic Adenocarcinoma

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial evaluates the impact of telehealth self-management coaching sessions on quality of life in pancreatic cancer survivors and their family care givers (FCGs). Patients with pancreatic cancer experience many symptoms because of the disease and treatment, which can have a negative impact on quality of life. Patients and their families have unmet needs during treatment, including a lack of quality of life programs that offer support to patients. Supporting patients and families on managing the physical symptoms, emotional well-being, social well-being and spiritual well-being with telehealth self-management coaching sessions may help improve quality of life, manage symptoms from treatment, and support families in their role as caregivers during treatment.

Official Title

Impacting Quality of Life and Pancreatic Cancer Survivorship Through a Telehealth Intervention

Quick Facts

Study Start:2024-10-07
Study Completion:2027-05-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06524973

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * • PATIENT: Documented informed consent of the participant and/or legally authorized representative
  2. * Assent, when appropriate, will be obtained per institutional guidelines
  3. * PATIENT: Age: ≥ 18 years
  4. * PATIENT: Eastern Cooperative Oncology Group (ECOG) ≤ 2
  5. * PATIENT: Ability to read and understand English or Spanish for questionnaires
  6. * PATIENT: Subjects must have histologically or cytologically confirmed diagnosis of metastatic pancreatic adenocarcinoma who are within 8 weeks of initial diagnosis
  7. * FAMILY CARE GIVER: Documented informed consent of the participant and/or legally authorized representative
  8. * Assent, when appropriate, will be obtained per institutional guidelines
  9. * FAMILY CARE GIVER: Age: ≥ 18 years
  10. * FAMILY CARE GIVER: Ability to read and understand English or Spanish for questionnaires
  11. * FAMILY CARE GIVER: A family member or friend identified by the patient and defined as a person who knows the patient well and is involved in the patient's medical care
  1. * • An employee who is under the direct/ indirect supervision of the principal investigator (PI)/ a co-investigator/ the study manager
  2. * A direct study team member

Contacts and Locations

Study Contact

Vincent Chung, MD
CONTACT
626-359-8111
vchung@coh.org

Principal Investigator

Vincent Chung, MD
PRINCIPAL_INVESTIGATOR
City of Hope Medical Center

Study Locations (Sites)

City of Hope at Arcadia
Arcadia, California, 91007
United States
City of Hope Corona
Corona, California, 92879
United States
City of Hope at Duarte
Duarte, California, 91010
United States
City of Hope Comprehensive Cancer Center
Duarte, California, 91010
United States
City of Hope at Glendale
Glendale, California, 91204
United States
City of Hope at Glendora
Glendora, California, 91741
United States
City of Hope Seacliff
Huntington Beach, California, 92648
United States
City of Hope at Irvine Lennar
Irvine, California, 92618
United States
City of Hope at Irvine Sand Canyon
Irvine, California, 92618
United States
City of Hope Antelope Valley
Lancaster, California, 93534
United States
City of Hope at Long Beach Worsham
Long Beach, California, 90808
United States
City of Hope at Long Beach Elm
Long Beach, California, 90813
United States
City of Hope Mission Hills
Mission Hills, California, 91345
United States
City of Hope at Newport Beach Fashion Island
Newport Beach, California, 92660
United States
City of Hope at Palmdale
Palmdale, California, 93551
United States
City of Hope - Santa Clarita
Santa Clarita, California, 91355
United States
City of Hope at Simi Valley
Simi Valley, California, 93065
United States
City of Hope South Pasadena
South Pasadena, California, 91030
United States
City of Hope at Thousand Oaks
Thousand Oaks, California, 91361
United States
City of Hope South Bay
Torrance, California, 90503
United States
City of Hope Upland
Upland, California, 91786
United States
City of Hope West Covina
West Covina, California, 91790
United States

Collaborators and Investigators

Sponsor: City of Hope Medical Center

  • Vincent Chung, MD, PRINCIPAL_INVESTIGATOR, City of Hope Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-07
Study Completion Date2027-05-03

Study Record Updates

Study Start Date2024-10-07
Study Completion Date2027-05-03

Terms related to this study

Additional Relevant MeSH Terms

  • Metastatic Pancreatic Adenocarcinoma